LabVantage COVID-19 LIMS Solution Launched for Workplace Health and Safety
An LIMS system enables a COVID-19 testing center for employees at their workplace.
LabVantage Solutions, a laboratory information management system provider based in Somerset, NJ, has a COVID-19 laboratory information management system (LIMS) solution that can be used for companies to improve employee health and safety in the workplace.
According to July 22, 2020 press release, a global consumer packaged goods (CPG) company has utilized the LIMS solution to open an in-house COVID-19 testing center where employees can be tested for the SARS-CoV-2 virus that causes COVID-19. Employees showing signs and symptoms of the virus, or those who request a test, can be scheduled for an appointment using the system.
LabVantage’s COVID-19 LIMS solution lets health professionals schedule, collect samples, test, track, and report results, the press release said. It comes preconfigured to prepare sample requests, label sample specimens, and track patient and sample data while following privacy and security protocols, and it handles results and reporting in a single interface.
Source: LabVantage
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
